JAK2V617F mutationBiomarker1 paperHumans1LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 1Oct 2026: 02European Journal of HaematologyHumans·1 SepHigh Prevalence of the JAK2V617F Mutation in Patients With Acute Coronary SyndromeMechanismsFrontiers in OncologyReview·26 AugNeutrophil-to-lymphocyte ratio as a gene-specific biomarker of JAK2-driven inflammation across CHIP and myeloproliferative neoplasmsNeutrophil-to-lymphocyte ratio
European Journal of HaematologyHumans·1 SepHigh Prevalence of the JAK2V617F Mutation in Patients With Acute Coronary SyndromeMechanisms
Frontiers in OncologyReview·26 AugNeutrophil-to-lymphocyte ratio as a gene-specific biomarker of JAK2-driven inflammation across CHIP and myeloproliferative neoplasmsNeutrophil-to-lymphocyte ratio